Clomicalm (40 - 80 kg)
Active substance
ATC code
Species
Dogs.
Indications
As an aid in the treatment of separation-related disorders in dogs manifested by destruction and inappropriate elimination (defaecation and urination) and only in combination with behavioural modification techniques.
Dose to be administered and administration route
Oral use.
The veterinary medicinal product should be administered orally at a dose of 1-2 mg/kg clomipramine twice daily to give a total daily dose of 2-4 mg/kg according to the following table:
Dosage per administration | |||
Body weight | Clomicalm 5 mg | Clomicalm 20 mg | Clomicalm 80 mg |
1.25 - 2.5 kg | ½ tablet | ||
> 2.5 - 5 kg | 1 tablet | ||
> 5 - 10 kg | ½ tablet | ||
> 10 - 20 kg | 1 tablet | ||
> 20 - 40 kg | ½ tablet | ||
> 40 - 80 kg | 1 tablet | ||
To ensure a correct dosage, body weight should be determined as accurately as possible. The use of suitably calibrated measuring equipment is recommended.
The veterinary medicinal product may be given orally with or without food.
In clinical trials, a treatment time of 2-3 months with the veterinary medicinal product in combination with behavioural modification techniques was sufficient to control the symptoms of separation-related disorders. Some cases may require longer treatment. In cases showing no improvement after 2 months, treatment with the veterinary medicinal product should be ceased.
Adverse reactions
Dogs:
Very rare (< 1 animal / 10,000 animals treated, including isolated reports): | Appetite disorder2, Lethargy2 Elevated liver enzymes2 Convulsion, Mydriasis4 Agression |
Undetermined frequency (cannot be estimated from the available data): |
authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
